* Ariad reports first quarter 2016 financial results and
progress on strategic review
The post BRIEF-Ariad Pharmaceuticals posts Q1 loss per share $0.28 appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Ariad reports first quarter 2016 financial results and
progress on strategic review
The post BRIEF-Ariad Pharmaceuticals posts Q1 loss per share $0.28 appeared first on NASDAQ.